Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China
· Delayed Price · Currency is CNY 19.61
+0.95 (5.09%)
Mar 10, 2026, 2:25 PM CST
SHE:002082 Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 439.15M CNY in the quarter ending September 30, 2025, with 36.51% growth. This brings the company's revenue in the last twelve months to 1.39B, down -13.26% year-over-year. In the year 2024, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.44B, down -6.39%.
Revenue (ttm)
1.39B
Revenue Growth
-13.26%
P/S Ratio
9.97
Revenue / Employee
763.65K
Employees
1,499
Market Cap
11.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | 13.70B | -2.99B | -17.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Porton Pharma Solutions | 3.43B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Zhejiang CONBA Pharmaceutical | 6.58B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 5.49B |
| Shanghai Yizhong Pharmaceutical | 317.08M |